Skip to Main Content

Author Details

Jennifer L Goldman
Children's Mercy Hospitals and Clinics
2004
93
17
PMIDPaper TitleJournal TitlePublished Year
35867691Guideline-Concordant Antiviral Treatment in Children at High Risk for Influenza Complications.Clin Infect Dis2023
37394512Building School-Academic Partnerships to Implement COVID-19 Testing in Underserved Populations.Pediatrics2023
37394509A COVID-19 Testing Preference Study in Schools.Pediatrics2023
37394504Utilization and Impact of Symptomatic and Exposure SARS-CoV-2 Testing in K-12 Schools.Pediatrics2023
37394502A Multi-Study Synthesis of Facilitators and Barriers to SARS-CoV-2 Testing Enrollment in School Settings.Pediatrics2023
37394503Common Data Element Collection in Underserved School Communities: Challenges and Recommendations.Pediatrics2023
37449964Definition and Clinical Evaluation for Trimethoprim-Sulfamethoxazole Severe Acute Respiratory Failure.Crit Care Med2023
37440445Notes from the Field: Multipathogen Respiratory Virus Testing Among Primary and Secondary School Students and Staff Members in a Large Metropolitan School District - Missouri, November 2, 2022-April 19, 2023.MMWR Morb Mortal Wkly Rep2023
36448681Adherence to antimicrobial agent recommendations and utilization during drug shortages.Am J Health Syst Pharm2023
36855275Advancing pediatric medication safety using real-world data: Current problems and potential solutions.J Hosp Med2023
36714293Increasing cefazolin use for surgical prophylaxis in penicillin-allergy-labeled patients.Antimicrob Steward Healthc Epidemiol2023
36601546Variation in antibiotic resistance patterns for children and adults treated at 166 non-affiliated US facilities using EHR data.JAC Antimicrob Resist2023
36564960Polypharmacy among medicaid-insured children with and without documented obesity.Pharmacotherapy2023
36412278SARS-CoV-2 Screening Testing Programs for Safe In-person Learning in K-12 Schools.J Pediatric Infect Dis Soc2023
36039957Novel expansion of a well-established antimicrobial stewardship program: Enhancing program efficiency and reach.Infect Control Hosp Epidemiol2023
34737173Implementation of School-Based COVID-19 Testing Programs in Underserved Populations.Pediatrics2022
35504578Inpatient outcomes for children receiving empiric methicillin-resistant Staphylococcus aureus coverage for complicated pneumonia.J Hosp Med2022
35994276Modeling Cost and Outcomes of SARS-CoV-2 School Testing Programs.JAMA Pediatr2022
35044997Identification of Inappropriate Antibiotic Orders During Implementation of a Multidisciplinary Antimicrobial Stewardship Program Within the Primary Care Setting.J Patient Saf2022
34902014Evaluation of the Treatment of Aspiration Pneumonia in Hospitalized Children.J Pediatric Infect Dis Soc2022
35169303HLA-B*07:02 and HLA-C*07:02 are associated with trimethoprim-sulfamethoxazole respiratory failure.Pharmacogenomics J2022
35260896School Masking Policies and Secondary SARS-CoV-2 Transmission.Pediatrics2022
34737179Building a National Framework to Pair Scientists and Schools During a Global Pandemic.Pediatrics2022
34737176Urban Classification, Not COVID-19 Community Rates, Was Associated With Modes of Learning in US K-12 Schools?Pediatrics2022
32828798Novel outpatient antibiotic prescribing report of respiratory infections in a pediatric health system's emergency departments and urgent care clinics.Am J Infect Control2021
33718745Integration of a Lean Daily Management System into an Antimicrobial Stewardship Program.Pediatr Qual Saf2021
33513317Trimethoprim-Sulfamethoxazole-associated Fulminant Respiratory Failure in Children and Young Adults.Am J Respir Crit Care Med2021
33539569Too Much of a Good Thing: Defining Antimicrobial Therapeutic Targets to Minimize Toxicity.Clin Pharmacol Ther2021
33617439Readmissions Following Hospitalization for Infection in Children With or Without Medical Complexity.J Hosp Med2021
34763988Corrigendum to 'SJS/TEN 2019: From science to translation' [J. Dermatol. Sci. 98/1 (2020) 2-12].J Dermatol Sci2021
34593567Clinical Outcome and Antibiotic Dosing Differences by Weight in Children With Acute Osteomyelitis.Hosp Pediatr2021
34129705Risks and mitigation strategies to prevent etoposide infusion-related reactions in children.Pharmacotherapy2021
33990460Perceived Harm May Be Helpful: Fear of Fluoroquinolone-Associated Adverse Events in Children.Pediatrics2021
34096598Precision dosing of vancomycin: in defence of AUC-guided therapy in children.J Antimicrob Chemother2021
34235634Evaluating and Mitigating Risk of Acute Kidney Injury with the Combination of Vancomycin and Piperacillin-Tazobactam in Children.Paediatr Drugs2021
34031886Methods for Detecting Pediatric Adverse Drug Reactions From the Electronic Medical Record.J Clin Pharmacol2021
33439905Utilization of the Naranjo scale to evaluate adverse drug reactions at a free-standing children's hospital.PLoS One2021
32776356Enhancing Pediatric Adverse Drug Reaction Documentation in the Electronic Medical Record.J Clin Pharmacol2021
31421280Severe cutaneous adverse reactions: comparing outcomes in children with and without complex chronic conditions.J Allergy Clin Immunol Pract2020
33584083Screening Trimethoprim Primary Metabolites for Covalent Binding to Albumin.Med Chem Res2020
31937606Big Data in the Assessment of Pediatric Medication Safety.Pediatrics2020
31926758Nurses as antimicrobial stewards: Recognition, confidence, and organizational factors across nine hospitals.Am J Infect Control2020
32716487A Moving Target-Vancomycin Therapeutic Monitoring.J Pediatric Infect Dis Soc2020
32850118Pediatric SJS-TEN: Where are we now?F1000Res2020
32645472Implementation of a nurse-driven antibiotic engagement tool in 3 hospitals.Am J Infect Control2020
32236453Effectiveness and safety of mandatory antimicrobial indications and durations and a pharmacist-driven 48-hour time-out in a pediatric hospital.Am J Health Syst Pharm2020
32192826SJS/TEN 2019: From science to translation.J Dermatol Sci2020
29165624Cost and Potential Avoidability of Antibiotic-Associated Adverse Drug Reactions in Children.J Pediatric Infect Dis Soc2019
31792283An electronic medical records-based approach to identify idiosyncratic drug-induced liver injury in children.Sci Rep2019
29859332A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis.J Allergy Clin Immunol Pract2019
  • 1 - 50 of 93

Recommended Authors

Melissa Moore-Clingenpeel
Research Institute at Nationwide Children's Hospital
Career Start Year 2015
Number of shared co-authors 0
Hannah L Palac
Northwestern University Feinberg School of Medicine.
Career Start Year 2015
Number of shared co-authors 0
Matthew W McCarthy
Weill Cornell Medical College, New York-Presbyterian Hospital
Career Start Year 2014
Number of shared co-authors 0
Hayden T Schwenk
Stanford School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Monica V Mahoney
Department of Pharmacy, Beth Israel Deaconess Medical Center
Career Start Year 2013
Number of shared co-authors 0
George E Nelson
Vanderbilt University Medical Center
Career Start Year 2012
Number of shared co-authors 2
Son H McLaren
New York-Presbyterian Hospital
Career Start Year 2012
Number of shared co-authors 1
Erica S Shenoy
Massachusetts General Hospital
Career Start Year 2011
Number of shared co-authors 0
Maryrose Laguio-Vila
Rochester General Hospital
Career Start Year 2011
Number of shared co-authors 0
John C O'Horo
Mayo Foundation for Medical Education and Research
Career Start Year 2009
Number of shared co-authors 0
Kathleen Chiotos
Children's Hospital of Philadelphia
Career Start Year 2009
Number of shared co-authors 0
Shane J Cross
University of Tennessee Health Science Center
Career Start Year 2009
Number of shared co-authors 1
Anurag N Malani
Trinity Health St Joseph Mercy Hospital
Career Start Year 2005
Number of shared co-authors 1
Juan D Chaparro
Nationwide Children's Hospital
Career Start Year 2005
Number of shared co-authors 0
Amy L Potts
Department of Pharmacy, Monroe Carell Jr. Children's Hospital at Vanderbilt
Career Start Year 2004
Number of shared co-authors 3
Christopher R Frei
The University of Texas at Austin
Career Start Year 2003
Number of shared co-authors 0
Florence T Bourgeois
Boston Children's Hospital
Career Start Year 2002
Number of shared co-authors 1
Aditya H Gaur
St. Jude Children's Research Hospital
Career Start Year 2001
Number of shared co-authors 2
Shannon Manzi
Department of Pharmacy, Boston Children's Hospital
Career Start Year 1996
Number of shared co-authors 4
Fran Balamuth
Children's Hospital of Philadelphia and University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 2
Stephen J Teach
Center for Translational Research.
Career Start Year 1994
Number of shared co-authors 2
Priya Sampathkumar
Mayo Clinic
Career Start Year 1994
Number of shared co-authors 0
Carrie L Byington
UCSF School of Medicine, University of California Health
Career Start Year 1993
Number of shared co-authors 1
Daniel M Cohen
Nationwide Children's Hospital
Career Start Year 1992
Number of shared co-authors 2
Adrienne G Randolph
Boston Children's Hospital, Harvard Medical School
Career Start Year 1990
Number of shared co-authors 1
Preeti Jaggi
Emory University School of Medicine
Career Start Year 1989
Number of shared co-authors 1
Andrew T Pavia
University of Utah
Career Start Year 1987
Number of shared co-authors 3
Dianne Murphy
Career Start Year 1979
Number of shared co-authors 2
Richard Platt
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 1977
Number of shared co-authors 3
Donald A Goldmann
Boston Children's Hospital
Career Start Year 1973
Number of shared co-authors 2

Collaborators

Rangaraj Selvarangan
Children's Mercy Hospital
Co-authored papers 7
Matt Hall
University of Missouri-Kansas City
Co-authored papers 5
Bruce C Carleton
BC Children's Hospital Research Institute
Co-authored papers 4
Jeffery P Struewing
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 4
Samir S Shah
Division of Hospital Medicine.
Co-authored papers 4
Elizabeth J Phillips
Vanderbilt University Medical Center
Co-authored papers 4
Mark A Hoffman
Children's Mercy Hospital
Co-authored papers 3
Lisa M Wheatley
National Institutes of Health
Co-authored papers 3
Riichiro Abe
Co-authored papers 3
Emily E Haroz
Johns Hopkins University
Co-authored papers 3
Cynthia Sung
Health Services and Systems Research, Duke-NUS Medical School
Co-authored papers 3
James Chodosh
Harvard Medical School
Co-authored papers 3
Linda K Ko
Co-authored papers 2
Kyoung-Mee Kim
Seoul National University College of Medicine
Co-authored papers 2
Carlos G Grijalva
Vanderbilt University Medical Center
Co-authored papers 2
Alfonso Iovieno
University of British Columbia
Co-authored papers 2
Gianpiero L Cavalleri
School of Pharmacy and Biomolecular Sciences, Ireland FutureNeuro SFI Research Centre
Co-authored papers 2
Michael J Rieder
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 2
Simona Volpi
National Human Genome Research Institute
Co-authored papers 2
Robert M Califf
From the National Institutes of Health
Co-authored papers 1
Isaac S Kohane
Harvard Medical School
Co-authored papers 1
Jeffrey S Brown
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 1
Martin S Zand
University of Rochester Medical Center
Co-authored papers 1
Michiyo Sakiyama
the Lifestyle Related Disease Medical Center
Co-authored papers 1
Robert L Davis
Center for Biomedical Informatics, University of Tennessee Health Science Center
Co-authored papers 1
Sara L Van Driest
National Institutes of Health
Co-authored papers 1
Joshua C Denny
Vanderbilt University
Co-authored papers 1
Matthew K Nock
Harvard University
Co-authored papers 1
Shohko Sekine
School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
Co-authored papers 1
William O Cooper
Vanderbilt University School of Medicine
Co-authored papers 1
Release 1.2